Correlation Between Bank of China and Cansino Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank of China and Cansino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of China and Cansino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of China and Cansino Biologics, you can compare the effects of market volatilities on Bank of China and Cansino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of China with a short position of Cansino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of China and Cansino Biologics.

Diversification Opportunities for Bank of China and Cansino Biologics

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Bank and Cansino is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Bank of China and Cansino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cansino Biologics and Bank of China is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of China are associated (or correlated) with Cansino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cansino Biologics has no effect on the direction of Bank of China i.e., Bank of China and Cansino Biologics go up and down completely randomly.

Pair Corralation between Bank of China and Cansino Biologics

Assuming the 90 days trading horizon Bank of China is expected to generate 5.01 times less return on investment than Cansino Biologics. But when comparing it to its historical volatility, Bank of China is 4.11 times less risky than Cansino Biologics. It trades about 0.12 of its potential returns per unit of risk. Cansino Biologics is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  4,141  in Cansino Biologics on September 25, 2024 and sell it today you would earn a total of  1,995  from holding Cansino Biologics or generate 48.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bank of China  vs.  Cansino Biologics

 Performance 
       Timeline  
Bank of China 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bank of China are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Bank of China may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Cansino Biologics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Cansino Biologics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Cansino Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.

Bank of China and Cansino Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank of China and Cansino Biologics

The main advantage of trading using opposite Bank of China and Cansino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of China position performs unexpectedly, Cansino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cansino Biologics will offset losses from the drop in Cansino Biologics' long position.
The idea behind Bank of China and Cansino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Commodity Directory
Find actively traded commodities issued by global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments